D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOGM
651
DELISTED
LogMein, Inc.
LOGM
| $14.3M | 0.02% |
178,882
+105,067
| +142% | +$8.42M |
|
652
Cummins
CMI
$56.6B
| $14.3M | 0.02% |
90,486
+27,832
| +44% | +$4.39M |
|
653
Performance Food Group
PFGC
$16.6B
| $14.3M | 0.02% |
359,680
-71,687
| -17% | -$2.84M |
|
654
Stratasys
SSYS
$839M
| $14.3M | 0.02% |
598,227
+405,421
| +210% | +$9.66M |
|
655
Groupon
GRPN
$950M
| $14.2M | 0.02% |
200,625
+26,522
| +15% | +$1.88M |
|
656
Huntington Ingalls Industries
HII
$10.8B
| $14.2M | 0.02% |
68,606
+46,469
| +210% | +$9.63M |
|
|
ENDP
657
DELISTED
Endo International plc
ENDP
| $14.2M | 0.02% |
1,764,691
-1,575,875
| -47% | -$12.7M |
|
658
GameStop
GME
$11.1B
| $14.1M | 0.02% |
5,556,972
+4,794,308
| +629% | +$12.2M |
|
659
Mercury Systems
MRCY
$4.38B
| $14.1M | 0.02% |
220,056
+57,316
| +35% | +$3.67M |
|
660
iRhythm Technologies
IRTC
$5.81B
| $14.1M | 0.02% |
187,552
+106,380
| +131% | +$7.97M |
|
661
Neurocrine Biosciences
NBIX
$14.2B
| $14M | 0.02% |
159,284
-51,239
| -24% | -$4.51M |
|
662
Designer Brands
DBI
$225M
| $14M | 0.02% |
631,459
+383,957
| +155% | +$8.53M |
|
|
QUOT
663
DELISTED
Quotient Technology Inc
QUOT
| $14M | 0.02% |
1,414,974
+230,584
| +19% | +$2.28M |
|
664
Sibanye-Stillwater
SBSW
$6.18B
| $13.8M | 0.02% |
3,337,459
| – | – |
|
665
Cimpress
CMPR
$1.5B
| $13.7M | 0.02% |
170,960
-134,006
| -44% | -$10.7M |
|
666
Jack Henry & Associates
JKHY
$11.8B
| $13.6M | 0.02% |
98,363
+30,990
| +46% | +$4.3M |
|
667
Wingstop
WING
$7.66B
| $13.6M | 0.02% |
179,117
+130,617
| +269% | +$9.93M |
|
668
Amicus Therapeutics
FOLD
$2.48B
| $13.6M | 0.02% |
1,000,626
+109,646
| +12% | +$1.49M |
|
669
Brixmor Property Group
BRX
$8.6B
| $13.6M | 0.02% |
738,421
-998,716
| -57% | -$18.3M |
|
670
Lincoln National
LNC
$7.99B
| $13.5M | 0.02% |
230,674
+177,581
| +334% | +$10.4M |
|
|
MXIM
671
DELISTED
Maxim Integrated Products
MXIM
| $13.5M | 0.02% |
254,549
-200,724
| -44% | -$10.7M |
|
|
ADSW
672
DELISTED
Advanced Disposal Services, Inc.
ADSW
| $13.5M | 0.02% |
482,477
+33,059
| +7% | +$926K |
|
673
Varex Imaging
VREX
$477M
| $13.5M | 0.02% |
398,610
-57,964
| -13% | -$1.96M |
|
674
Tactile Systems Technology
TCMD
$305M
| $13.4M | 0.02% |
253,979
+229,514
| +938% | +$12.1M |
|
675
Madison Square Garden
MSGS
$5.09B
| $13.4M | 0.02% |
+63,951
| New | +$13.4M |
|